Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
9/16/2021
0:00
34:49
Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
More episodes from "JAMA Oncology Author Interviews"
Don't miss an episode of “JAMA Oncology Author Interviews” and subscribe to it in the GetPodcast app.